Dana-Farber Cancer Institute, Boston, Massachusetts 02215; email:
Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142.
Annu Rev Pathol. 2017 Jan 24;12:217-244. doi: 10.1146/annurev-pathol-012615-044305. Epub 2016 Dec 5.
Established infectious agents continue to be a major cause of human morbidity and mortality worldwide. However, the causative agent remains unknown for a wide range of diseases; many of these are suspected to be attributable to yet undiscovered microorganisms. The advent of unbiased high-throughput sequencing and bioinformatics has enabled rapid identification and molecular characterization of known and novel infectious agents in human disease. An exciting era of microbe discovery, now under way, holds great promise for the improvement of global health via the development of antimicrobial therapies, vaccination strategies, targeted public health measures, and probiotic-based preventions and therapies. Here, we review the history of pathogen discovery, discuss improvements and clinical applications for the detection of microbially associated diseases, and explore the challenges and strategies for establishing causation in human disease.
已确立的传染病仍然是全球人类发病率和死亡率的主要原因。然而,对于广泛的疾病,其病原体仍然未知;其中许多疾病被怀疑是由尚未发现的微生物引起的。无偏高通量测序和生物信息学的出现,使得在人类疾病中快速鉴定和分子特征分析已知和新型传染病病原体成为可能。目前正在进行的微生物发现的激动人心的时代,通过开发抗菌治疗、疫苗策略、有针对性的公共卫生措施以及基于益生菌的预防和治疗,为改善全球健康带来了巨大的希望。在这里,我们回顾了病原体发现的历史,讨论了与微生物相关疾病检测的改进和临床应用,并探讨了在人类疾病中建立因果关系的挑战和策略。